Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Respiratory diseases Stories

2011-12-14 09:35:00

BANNOCKBURN, Ill., Dec. 14, 2011 /PRNewswire/ -- Pinnacle Biologics, Inc., a privately held specialty bio-pharmaceutical company announced today that it has obtained approval for an Orphan Drug Designation (ODD) for their product PHOTOFRIN® (porfimer sodium) as adjuvant therapy to surgery in the treatment of malignant pleural mesothelioma. Malignant pleural mesothelioma is a form of cancer affecting the lining of the lungs. It is a rare, highly aggressive and...

2011-12-07 08:00:00

REDWOOD CITY, Calif., Dec. 7, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist (LAMA) delivered twice a day (BID) via metered-dose inhaler (GP MDI; PT001) in patients with moderate-to-severe COPD. Four doses of GP MDI were compared to placebo and Atrovent® HFA Inhalation Aerosol, a short-acting muscarinic...

2011-12-01 08:00:00

Surviving Mesothelioma reports that the incidence of mesothelioma and the number of countries whose citizens are dying of this disease are both on the rise. (PRWEB) December 01, 2011 Surviving Mesothelioma reports that the incidence of mesothelioma and the number of countries whose citizens are dying of this disease are both on the rise. A recent World Health Organization (WHO) bulletin reports that more than 92,000 people in 83 countries died of mesothelioma between 1994 and 2008. The...

2011-11-29 07:03:00

TUSTIN, Calif., Nov. 29, 2011 /PRNewswire/ -- Uptake Medical® today announced the first commercial use of the InterVapor(TM) System for endoscopic lung volume reduction in a patient with severe emphysema. The patient successfully underwent treatment with InterVapor, the first endoscopic lung volume reduction system for the treatment of severe emphysema that uses the body's natural healing processes without leaving foreign materials in the lung. The patient was treated by the...

2011-11-18 00:20:01

Tokyo, Nov 18, 2011 - (JCN Newswire) - Eisai Co. Ltd announced today that it has entered into a Japan co-promotion agreement with Novartis Pharma K.K. for three Novartis Pharma therapies for chronic obstructive pulmonary disease (COPD). These include Onbrez Inhalation Capsules 150 mcg (indacaterol maleate), which were launched in Japan on September 20, 2011, and, if approved, the investigational drugs NVA237 (glycopyrronium bromide) and QVA149 (fixed-dose combination of indacaterol maleate...

2011-11-16 07:27:53

Early screening of patients with chronic obstructive pulmonary disease (COPD) may help to detect lung cancer at an earlier stage, according to a new study. The research, published online today (16 November 2011) in the European Respiratory Journal, suggests that if COPD can be detected at an earlier stage, this will also aid the early detection of lung cancer. The news comes on World COPD Day, which aims to improve awareness of the condition and care of people with COPD around the...

2011-11-16 03:00:00

ZURICH, November 16, 2011 /PRNewswire/ -- - Updated international treatment guidelines confirm experts' views that prevention of COPD exacerbations should be of equal importance to relieving daily symptoms - New data confirms COPD patients are at increased risk during winter, experiencing an increase in exacerbations, increasing the risk of long-term damage and more rapid disease progression - Patients should...

2011-11-14 11:00:00

As consumers seek answers tailored to their personal health needs, MedHelp provides a unique ability to improve doctor-patient communication and connect patients to the #1 respiratory hospital in the U.S. San Francisco, CA (PRWEB) November 14, 2011 MedHelp, the worldâs largest health social network, and National Jewish Health, the #1 respiratory hospital in the United States located in Denver, CO, recently celebrated their tenth anniversary of partnering to provide consumers...

2011-11-11 08:00:00

MesoAuthority is the largest collection of resource sites on the internet for families and victims of mesothelioma and asbestos exposure. Los Angeles, CA (PRWEB) November 11, 2011 In an effort to help those families and victims of asbestos exposure and the deadly cancer mesothelioma with all legal needs, The Sizemore Law Firm is pleased to announce the launch of MesoAuthority.com. The largest collection of asbestos and mesothelioma resource sites on the internet, MesoAuthority.com provides...

2011-11-10 17:44:00

SAN DIEGO, Nov. 10, 2011 /PRNewswire/ -- Synteract, Inc., a full-service, global contract research organization (CRO), and MediciNova, Inc., a publicly traded biopharmaceutical company focused on novel, small-molecule therapeutics for the treatment of serious diseases, will team up to support the American Lung Association (ALA) in California in their annual Fight For Air Walk through team participation and donations. The two companies also are working together on a Phase 2 trial studying...